| HOME >> MEDICINE >> TECHNOLOGY |
The following table includes the GAAP income statement for for the three month periods ending 2012 and 2011:THORATEC CORPORATIONCondensed Consolidated Statements(Unaudited)(in thousands, except for per share data) Three Months Ended March 31, 2012April 2, 2011Product sales$
26,769$
99,530Cost of product sales38,88731,772Gross profit87,88267,758Operating expenses:Selling, general and administrative31,20124,919Research and development19,69615,754Total operating expenses50,89740,673Income from operations36,98527,085Other income and (expense):Interest expense(3)(2,880)Interest income and other734755Income before income taxes37,71624,960Income tax expense (12,230)(8,501)Net income$
25,486$
,459Net income per share- Basic:$
.44$
.28Net income per share- Diluted:$
.43$
.27Shares used to compute net income per share:Basic58,43857,932Diluted59,38265,881
The following table presents our quarterly revenues by source for the first quarter of fiscal 2012 and the full year of fiscal 2011:THORATEC CORPORATIONQuarterly Revenue Analysis(Unaudited)(in millions) Three Months Ended March 31, 2012December 31, 2011October 1, 2011July 2, 2011April 2, 2011Revenue by Product LineHeartMate
$
.7$
93.8$
87.6$
97.6$
87.3PVAD & IVAD
5.86.17.27.67.3CentriMag (1)
8.78.87.25.34.4Other
0.60.70.60.70.5Total
$
26.8$
9.4$
2.6$
.2$
99.5Revenue by CategoryPump
$
92.6$
77.4$
72.2$
77.8$
70.8Non-Pump
33.631.329.832.728.2Other
0.60.70.60.70.5Total
$
26.8$
9.4$
2.6$
.2$
99.5Revenue by GeographyUnited States
$
3.9$
88.2$
83.9$
93.0$
82.5International
22.921.218.718.217.0Total
$
26.8$
9.4$
2.6$
.2$
99.5(1) CentriMag includes PediMag/PediVAS® sales
The following table presents our quarterly pump units by geography for
'/>"/>
| SOURCE Thoratec Corporation Copyright©2010 PR Newswire. All rights reserved |